» Articles » PMID: 36609122

Novel Therapies and Innovation for Systemic Sclerosis Skin Ulceration

Overview
Publisher Elsevier
Specialty Rheumatology
Date 2023 Jan 7
PMID 36609122
Authors
Affiliations
Soon will be listed here.
Abstract

Skin ulceration is an important cause of morbidity in systemic sclerosis and can occur at anytime during disease progression. Incident disease cohorts are important for understanding whether skin ulceration represents active vasculopathy versus resultant damage. Biomarkers for skin ulcer pathogenesis, both serum and imaging, are under investigation to elucidate the functional consequences of the structural abnormalities. Novel therapeutics for the treatment of vasculopathy benefit from reliable biomarkers able to predict the disease evolution remains an important unmet need. Nonetheless, a diagnostic approach that captures early skin ulceration and treatments that restore vascular and immune homeostasis is critical for effective systemic sclerosis (SSc) vasculopathy management.

Citing Articles

Mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis: role and therapeutic directions.

Wang X, Guo J, Dai Q Front Cell Dev Biol. 2024; 12:1492821.

PMID: 39483335 PMC: 11524835. DOI: 10.3389/fcell.2024.1492821.


Biomarkers in Systemic Sclerosis: An Overview.

Di Maggio G, Confalonieri P, Salton F, Trotta L, Ruggero L, Kodric M Curr Issues Mol Biol. 2023; 45(10):7775-7802.

PMID: 37886934 PMC: 10604992. DOI: 10.3390/cimb45100490.


Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis.

Muruganandam M, Ariza-Hutchinson A, Patel R, Sibbitt Jr W J Inflamm Res. 2023; 16:4633-4660.

PMID: 37868834 PMC: 10590076. DOI: 10.2147/JIR.S379815.


Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography.

DAlessandro R, Gonzalez E, Falsetti P, Conticini E, DAlessandro M, Selvi E Life (Basel). 2023; 13(2).

PMID: 36836844 PMC: 9962179. DOI: 10.3390/life13020487.

References
1.
Liu X, Gao N, Li M, Xu D, Hou Y, Wang Q . Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction. PLoS One. 2013; 8(6):e64531. PMC: 3679128. DOI: 10.1371/journal.pone.0064531. View

2.
Zhao Z, Patrinely Jr J, Saknite I, Byrne M, Tkaczyk E . Guideline for in vivo assessment of adherent and rolling leukocytes in human skin microvasculature via reflectance confocal videomicroscopy. Microcirculation. 2021; 28(8):e12725. PMC: 8602735. DOI: 10.1111/micc.12725. View

3.
Frech T, McNeill C, Lebiedz-Odrobina D, Lewis G . Amniotic membrane dressings: an effective therapy for SSc-related wounds. Rheumatology (Oxford). 2018; 58(4):734-736. PMC: 6434372. DOI: 10.1093/rheumatology/key410. View

4.
Levesque H, Baudot N, Delpech B, Vayssairat M, Gancel A, Lauret P . Clinical correlations and prognosis based on hyaluronic acid serum levels in patients with progressive systemic sclerosis. Br J Dermatol. 1991; 124(5):423-8. DOI: 10.1111/j.1365-2133.1991.tb00619.x. View

5.
Silva I, Teixeira A, Oliveira J, Almeida R, Vasconcelos C . Endothelial dysfunction, microvascular damage and ischemic peripheral vasculopathy in systemic sclerosis. Clin Hemorheol Microcirc. 2017; 66(2):117-130. DOI: 10.3233/CH-150044. View